You can now read 10 articles in a month for free on Read as much as you want anywhere and anytime for just 99¢.

The Boston Globe


Former Millennium CEO to head EnVivo

Deborah Dunsire, who in May resigned suddenly as Millennium Pharmaceutical’s chief executive, will return to the biotechnology industry to lead EnVivo Pharmaceuticals Inc.

Dunsire, 51, one of the best-known women in the life-sciences field, said she will start in mid-August as chief executive of EnVivo, a Watertown maker of drugs to treat central nervous system disorders. Its lead drug candidate, which is entering late-stage clinical trials, seeks to improve cognition for patients suffering from schizophrenia and Alzheimer’s disease.

Loading comments...

You have reached the limit of 10 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week